Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation.

IF 4.3 3区 医学 Q2 CHEMISTRY, MULTIDISCIPLINARY
Sideequl Akbar, Adarsh Malgave, Anumol Joseph, Ankit Kumar, Rajkumar Malayandi
{"title":"Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation.","authors":"Sideequl Akbar, Adarsh Malgave, Anumol Joseph, Ankit Kumar, Rajkumar Malayandi","doi":"10.1007/s11095-026-04094-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Semaglutide (SMG), a clinically relevant peptide-based therapeutic whose physical and chemical stability are critical concerns during manufacturing and storage. Although the stability of SMG in solution has been extensively studied, its solid-state behaviour remains unclear. This study aimed to systematically evaluate the impact of thermal stress on the solid-state physicochemical stability of SMG.</p><p><strong>Methods: </strong>The solid-state stability of SMG was assessed using complementary analytical techniques, including Fourier transform-infrared (FT-IR) spectroscopy, circular dichroism (CD), differential scanning calorimetry (DSC), hot-stage microscopy (HSM), reverse-phase high-performance liquid chromatography (RP-HPLC), and liquid chromatography-high-resolution mass spectrometry (LC-HRMS).</p><p><strong>Results: </strong>FT-IR and CD analyses demonstrated that SMG retains its native α-helical conformation up to 60°C. However, the α-helical content decreased from 49.07% to 43.75% at 60°C and further to 0.2% at 80°C, indicating extensive conformational transitions at elevated temperatures that compromise receptor binding and in vivo performance. DSC and HSM confirmed that SMG remains amorphous under all tested conditions and revealed three major thermal events: residual water loss, enthalpy recovery associated with physical ageing, and thermal decomposition. The overlap of enthalpy recovery with the glass transition phase limited the determination of Tg by conventional DSC; however, modulated DSC enabled the separation of these events, establishing a Tg of 169°C. RP-HPLC and LC-HRMS analyses showed a temperature-dependent degradation and impurity formation.</p><p><strong>Conclusion: </strong>The solid-state stability study identified temperature as a critical factor influencing SMG stability and emphasises the importance of stringent process control in the development of SMG-based formulations.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11095-026-04094-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Semaglutide (SMG), a clinically relevant peptide-based therapeutic whose physical and chemical stability are critical concerns during manufacturing and storage. Although the stability of SMG in solution has been extensively studied, its solid-state behaviour remains unclear. This study aimed to systematically evaluate the impact of thermal stress on the solid-state physicochemical stability of SMG.

Methods: The solid-state stability of SMG was assessed using complementary analytical techniques, including Fourier transform-infrared (FT-IR) spectroscopy, circular dichroism (CD), differential scanning calorimetry (DSC), hot-stage microscopy (HSM), reverse-phase high-performance liquid chromatography (RP-HPLC), and liquid chromatography-high-resolution mass spectrometry (LC-HRMS).

Results: FT-IR and CD analyses demonstrated that SMG retains its native α-helical conformation up to 60°C. However, the α-helical content decreased from 49.07% to 43.75% at 60°C and further to 0.2% at 80°C, indicating extensive conformational transitions at elevated temperatures that compromise receptor binding and in vivo performance. DSC and HSM confirmed that SMG remains amorphous under all tested conditions and revealed three major thermal events: residual water loss, enthalpy recovery associated with physical ageing, and thermal decomposition. The overlap of enthalpy recovery with the glass transition phase limited the determination of Tg by conventional DSC; however, modulated DSC enabled the separation of these events, establishing a Tg of 169°C. RP-HPLC and LC-HRMS analyses showed a temperature-dependent degradation and impurity formation.

Conclusion: The solid-state stability study identified temperature as a critical factor influencing SMG stability and emphasises the importance of stringent process control in the development of SMG-based formulations.

Semaglutide的热应力固态稳定性:了解温度对蛋白质含量、二级结构、相变和化学降解的影响。
目的:Semaglutide (SMG)是一种临床相关的肽类药物,其物理和化学稳定性在生产和储存过程中至关重要。虽然SMG在溶液中的稳定性已被广泛研究,但其固态行为仍不清楚。本研究旨在系统评价热应力对SMG固态物理化学稳定性的影响。方法:采用互补分析技术,包括傅里叶变换红外光谱(FT-IR)、圆二色法(CD)、差示扫描量热法(DSC)、热级显微镜(HSM)、反相高效液相色谱法(RP-HPLC)和液相色谱-高分辨率质谱法(LC-HRMS),评估SMG的固态稳定性。结果:FT-IR和CD分析表明,SMG在60°C时仍保持其天然α-螺旋构象。然而,α-螺旋含量在60°C时从49.07%下降到43.75%,在80°C时进一步下降到0.2%,表明高温下广泛的构象转变影响了受体结合和体内性能。DSC和HSM证实SMG在所有测试条件下都保持无定形,并揭示了三个主要的热事件:残余水分损失、与物理老化相关的焓恢复和热分解。焓恢复与玻璃化转变相的重叠限制了常规DSC法测定Tg;然而,调制DSC使这些事件分离,建立Tg为169°C。反相高效液相色谱(RP-HPLC)和液相色谱质谱(LC-HRMS)分析表明,其降解和杂质形成依赖于温度。结论:固态稳定性研究确定温度是影响SMG稳定性的关键因素,并强调了严格的工艺控制在SMG基配方开发中的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutical Research
Pharmaceutical Research 医学-化学综合
CiteScore
6.60
自引率
5.40%
发文量
276
审稿时长
3.4 months
期刊介绍: Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to: -(pre)formulation engineering and processing- computational biopharmaceutics- drug delivery and targeting- molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)- pharmacokinetics, pharmacodynamics and pharmacogenetics. Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书